Clinical Trials Browser

Withdrawn × Carcinoma, Renal Cell × durvalumab × Clear all

NCT04262375 2020-11-17

DOMINATION

Phase 2 Withdrawn

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell